Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have previously been diagnosed with type 2 diabetes
Who may not be able to join:
- People who have a type of diabetes other than type 2
- People whose blood sugar control (HbA1c) is already within the recommended target range, or whose levels are very high (above 12%)
- People with severe nerve damage (severe neuropathy)
- People with significantly reduced kidney function (confirm with trial site for specific measurement details)
- People with a life expectancy of less than 6 months
- People with alcohol dependence, other chemical dependence, or who are taking antipsychotic medications
- People with an autoimmune disease or who take steroid medications long-term
- People who have a condition where the stomach empties too slowly (gastroparesis)
- People who are pregnant or breastfeeding
- People who have had a serious heart event (such as a heart attack) within the last 60 days
- People who use a wheelchair
- People who have a cognitive, neurological, or psychiatric condition
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jussara C De Almeida, PhD, Federal University of Rio Grande do Sul
Phone: +555133598410
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in baseline HbA1C at 4 months; Change in baseline HbA1C at 8 months; Change in baseline HbA1C at 12 months; Change in diabetic retinopathy and baseline diabetic kidney disease at 12 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.